Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2012 by Mount Sinai Hospital, Canada.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Edward Margolin, Mount Sinai Hospital, Canada
ClinicalTrials.gov Identifier:
NCT00813059
First received: December 19, 2008
Last updated: February 6, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2012
  Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)